| http://www.w3.org/ns/prov#value | - This discrepancy highlights the importance of public payers and foundations, such as the Bill & Melinda Gates Foundation [47], the Rockefeller Foundation [48], and others, whose funding priorities reach beyond the U.S. boundaries.While funding was correlated with disease burden, it was not associated with an increase in new therapies, even when incorporating a lag of eight years between funding an
|
